Physician profile
Lisa E Meek
NPI 1043366107
$1,843.38
in general payments reported to CMS, 2019-2025
17 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $99.18 · 2021: $258 · 2022: $262 · 2023: $213 · 2024: $253 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $498.31 | 2019-2024 | |
| Allergan, INC. | $398.43 | 2019-2022 | |
| Abbvie INC. | $209.94 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $131.39 | 2022-2024 | Odomzo, Blu-U |
| Leo Pharma INC. | $108.20 | 2025 | Anzupgo |
| Amgen INC. | $92.88 | 2021-2024 | Otezla |
| Revance Therapeutics, INC. | $91.36 | 2024 | Daxxify |
| Incyte Corporation | $77.64 | 2021-2022 | |
| Genzyme Corporation | $51.69 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $41.59 | 2021-2024 | Libtayo |
| Merz North America, INC. | $34.87 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $25.42 | 2019-2020 | |
| Lilly USA, LLC | $20.68 | 2024 | Taltz |
| Biofrontera INC. | $16.29 | 2019-2022 | |
| Verrica Pharmaceuticals INC. | $15.65 | 2023 | Ycanth |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $14.79 | 2020 | |
| Dermira, INC. | $14.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Meek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.